Related by context. All words. (Click for frequent words.) 77 PI3K/Akt pathway inhibitor 75 huC# DM4 74 alvespimycin 74 IL# PE#QQR 74 Cloretazine ® 74 MAGE A3 ASCI 73 Phase #b/#a clinical 73 SAR# [004] 73 mertansine 73 PDX pralatrexate 73 telomerase therapeutic 73 oral prodrug 73 YONDELIS 73 forodesine 72 trastuzumab emtansine T DM1 72 phase IIb clinical 72 Phase Ib II 72 FOLOTYN ® 72 Zemiva TM 72 trastuzumab DM1 72 non nucleoside inhibitor 72 Proellex TM 72 GVAX ® 72 PANVAC VF 72 candidate CRLX# 72 PSMA ADC 72 ongoing Phase 1b 71 neratinib 71 Hedgehog Pathway Inhibitor 71 Quinamed 71 ThermoDox ® clinical 71 SinuNase ™ 71 FavId 71 PEG SN# 71 Curaxin CBLC# 71 BRIM3 71 Solazed TM 71 SinuNase TM 71 Phase IIb clinical trials 71 non nucleoside HCV 71 acyclovir Lauriad R 71 refractory gout 71 including eniluracil ADH 71 UPLYSO 71 Bayer HealthCare Onyx Pharmaceuticals 71 PNP inhibitor 71 PrevOnco ™ 71 PrevOnco 71 Fludara ® 71 oncolytic virus therapies 71 Phase Ib study 71 TLK# 71 Alocrest 71 leading oral taxane 70 Hepatocellular Carcinoma HCC 70 Civacir 70 TBC# 70 Vaxfectin TM 70 GRNVAC1 70 ganetespib 70 BrachySil TM 70 CINTREDEKIN BESUDOTOX 70 ocular formulation 70 TELINTRA 70 Cloretazine 70 LymphoStat B TM 70 R#/MEM # 70 IMA# 70 Tesetaxel 70 OncoVEX 70 HCV protease inhibitor 70 erlotinib Tarceva ® 70 Panzem R 70 ELACYT 70 tolevamer 70 Aplidin 70 Allovectin 7 70 sorafenib tablets 70 assessing T DM1 70 elotuzumab 70 refractory chronic lymphocytic 70 preclinical efficacy 70 docetaxel Taxotere ® 70 multicenter Phase II 70 Panzem R NCD 70 Xcellerated T Cells 70 talactoferrin 70 gefitinib Iressa 70 PORxin TM platforms 70 severe hypercholesterolemia 70 OvaRex ® MAb 70 Immunotherapeutic 70 CRMD# 70 rxRNA 70 Aurexis 70 BLP# Liposome Vaccine 70 Xanafide 70 Exherin TM 70 using ImmunoGen TAP 70 Dalbavancin 70 INCB# [001] 70 pharmacokinetic PK study 70 Aflibercept 70 Prodarsan R 70 receptor tyrosine kinase inhibitor 70 novel histone deacetylase 70 thalidomide Thalomid 70 acetonide FA 70 telomerase inhibitor drug 69 Onconase 69 perifosine KRX 69 kidney urologic 69 evaluating satraplatin 69 phase IIa clinical 69 adecatumumab MT# 69 PLK1 SNALP 69 Prostate AdenoCarcinoma Treatment 69 MOZOBIL 69 MyVax R 69 Factor VIIa 69 Squalamine 69 HDL Selective Delipidation 69 oral proteasome inhibitor 69 AEG# 69 liposomal formulation 69 Telatinib 69 Personalized Immunotherapy 69 Triapine R 69 ALN TTR# 69 oral antiviral 69 Elagolix 69 oral ridaforolimus 69 Phase Ib clinical 69 MGd 69 Phase 2a clinical trials 69 OvaRex R 69 hypoxia selective 69 personalized cellular immunotherapy 69 tramiprosate Alzhemed TM 69 ENMD # 69 LungAlert TM 69 aurora kinase 69 anticancer compound 69 Curaxin 69 ONCONASE R 69 fosbretabulin 69 Nexavar sorafenib 69 Aganocide ® 69 NPC 1C 69 Phase 1a clinical 69 TELCYTA 69 IMiDs ® 69 Azedra 69 GLP toxicology studies 69 Azedra ™ 69 huN# DM1 69 Phase IIb III 69 please visit www.advaxis.com 69 PDE4 inhibitor 69 proteasome inhibitor 69 tiapamil 69 NADiA 69 GAMMAGARD 69 Xcytrin R 69 ALN PCS 69 novel VDA molecule 69 Glufosfamide 69 CD# CEA 69 ZOLINZA 69 BACcel 69 Temsirolimus 69 OncoVex 69 JAK inhibitor 69 Phase III Pivotal 69 BRIM2 69 HGS ETR2 69 Plicera 69 CBLC# 69 daptomycin 69 Phase #/#a trial 69 SUTENT ® 69 nucleotide analogue 69 docetaxel Taxotere R 68 cediranib 68 Marqibo TM 68 histone deacetylase HDAC inhibitor 68 CCX# 68 HuMax TAC 68 Pivotal Phase III 68 phase Ib clinical 68 Nexavar ® 68 RGB # 68 Panzem NCD 68 HGS ETR1 mapatumumab 68 Hedgehog antagonist 68 recurrent metastatic ovarian cancer 68 volociximab 68 Aryplase 68 Kosan dependence 68 Proxinium TM 68 CA9 SCAN 68 bevacizumab Avastin ® 68 oral picoplatin 68 enzastaurin 68 Androxal TM 68 panitumumab Vectibix 68 PRECISE trial 68 Trastuzumab DM1 68 TASKi2 68 myelofibrosis polycythemia vera 68 ZEVALIN ® 68 CYT# potent vascular disrupting 68 delivers fluocinolone acetonide FA 68 ZACTIMA 68 GALNS 68 Phase 1b clinical trials 68 evaluating tivozanib 68 CR# vcMMAE 68 SUCCEED trial 68 Panzem 68 BAY #-# 68 virus HCV protease inhibitor 68 Matrix Phase 2b 68 lexidronam injection 68 Zemiva ™ 68 ALN TTR 68 monoclonal antibody conjugated 68 Aurora kinase inhibitor 68 MKC# MT 68 Vitaxin 68 oral ghrelin agonist 68 Azedra TM 68 initiated Phase Ib 68 HCD# [002] 68 Initiates Phase II 68 IMiDs R 68 adecatumumab 68 XL# SAR# 68 Archexin 68 Tarceva TM 68 SPRYCEL ® 68 antibody MAb 68 metaglidasen 68 Vicriviroc 68 lenalidomide Revlimid R 68 pan HDAC inhibitor 68 vaccines oncolytic virus 68 Zenvia ™ 68 modified glutathione analog 68 investigational humanized monoclonal antibody 68 fidaxomicin Phase 68 Romidepsin 68 next generation URAT1 68 Carfilzomib 68 investigational oral hepatitis C 68 therapeutic monoclonal antibody 68 Cintredekin Besudotox 68 Combination REOLYSIN R 68 Cloretazine VNP#M 68 oral taxane 68 phase IIb III 68 IMC #B 68 Genasense ® oblimersen 68 BiovaxID TM 68 Gemzar ® 68 5 fluorouracil leucovorin 68 AERx ® 68 R sorafenib tablets 68 ® bortezomib 68 midstage trials 68 midstage clinical 68 ToGA 68 LEUKINE 68 Onalta ™ 68 TELINTRA R 68 radiation sensitizer 68 HGS# 68 Velcade bortezomib 68 OncoVEX GM CSF 68 targeted radiotherapeutic 68 AAG geldanamycin analog 68 EGS# 68 Geron telomerase inhibitor 68 bortezomib Velcade 68 VEGFR2 inhibitor 68 BLA filing 68 rALLy clinical trial 68 lorvotuzumab mertansine 68 Exelixis compounds 68 HER2 positive metastatic breast 68 MKC# MKC# PP 68 Iluvien ® 68 CRLX# 68 vinorelbine tartrate 68 DEB# 68 Nasdaq ONXX today 68 recombinant PSMA vaccine 68 tubulin inhibitor 68 Fodosine 67 ospemifene 67 oral methylnaltrexone 67 Fibrin Pad 67 eTag assays 67 Phase Ib clinical trials 67 apricitabine ATC 67 NP2 Enkephalin 67 Cleviprex TM clevidipine 67 CEQ# 67 Ozarelix 67 systemic RNAi therapeutic 67 KNS # 67 BrachySil ™ 67 Selective Electrochemical Tumor Ablation 67 Xeloda ® 67 phase IIb study 67 XL# anticancer compounds 67 TOCOSOL Camptothecin 67 vemurafenib 67 phase IIa 67 Ramoplanin 67 Completes Patient Enrollment 67 Initiate Phase 67 Bezielle 67 treat chronic sinusitis 67 Xelox 67 sunitinib malate 67 PROSTASCINT R 67 Virulizin ® 67 TransVax TM 67 generation purine nucleoside 67 NASDAQ CXSP announced 67 phase IIb 67 dasatinib Sprycel ® 67 ARRY # 67 Rigel R# 67 lucinactant 67 HGS ETR1 67 BR.# 67 fidaxomicin Phase 3 67 axitinib 67 Ceflatonin 67 dextofisopam 67 Dacogen injection 67 Canvaxin 67 CTAP# Capsules 67 GetGoal Phase III 67 Iluvien TM 67 ThermoDox R 67 LEP ETU 67 Begins Dosing 67 Veronate 67 CCR5 inhibitor 67 Initiate Clinical Trial 67 pertuzumab 67 Altastaph 67 Phase 2b clinical 67 P#X# antagonist 67 TNFerade TM 67 TransVax 67 acyclovir Lauriad ® 67 HuMax EGFr 67 VivaGel ™ 67 EOquin TM 67 Initiates Clinical 67 sodium thiosulfate STS 67 Locteron ® 67 radezolid 67 INS# [001] 67 methylnaltrexone bromide 67 phase III isavuconazole 67 MEK inhibitor 67 cathepsin K inhibitor 67 novel therapeutic antibodies 67 ALTROPANE R 67 autologous cellular immunotherapy 67 BiTE R 67 oral nucleoside analogue 67 ruxolitinib 67 Trofex 67 IMPACS R 67 MEK inhibitors 67 interferon gamma 1b 67 Ceflatonin R 67 DCVax ® Brain 67 Afatinib 67 GVAX R 67 PF # [002] 67 vidofludimus 67 PROSTVAC TM 67 Alferon LDO 67 Prodarsan ® 67 Phase IIB 67 LE SN# 67 orally inhaled migraine 67 DPX Survivac 67 Lenocta 67 successfully commercialize Iluvien 67 Talabostat 67 galiximab 67 vinca alkaloid 67 evaluating T DM1 67 Safinamide 67 AzaSite TM 67 cariprazine 67 paclitaxel Taxol R 67 Allovectin 7 r 67 isavuconazole 67 PHX# 67 HQK 67 TASKi3 67 OHR/AVR# 67 SCIB1 67 ATL# [002] 67 investigational pan BCR 67 Initiates Enrollment 67 Specifid 67 evaluating bafetinib 67 LUX Lung 67 non nucleoside 67 PRT# 67 Amrubicin 67 Evoltra ® 67 cancer immunotherapies 67 Liprotamase 67 Deforolimus 67 gallium containing 67 Silodosin 67 AVASTIN 67 evaluating mipomersen 67 paclitaxel Taxol ® 67 selective orally bioavailable 67 Anturol ® 67 sulfonylhydrazine class 67 dose escalation clinical 67 EVIZON TM squalamine lactate 67 Cetuximab Erbitux 67 THR beta agonist 67 Chemophase 67 drug GAP #B# 67 CD3 monoclonal antibody 67 demonstrated antitumor activity 67 XYOTAX TM 67 CINQUIL 67 Genasense R oblimersen 67 histamine dihydrochloride 67 tafamidis 67 cetuximab Erbitux R 67 FOLFOX6 chemotherapy regimen 67 SPL# Gel vaginal microbicide 67 biliary tract cancer 67 etanercept Enbrel 66 Telik logo TELINTRA 66 AVE# 66 orally administered inhibitor 66 IMiDs ® compound 66 NASDAQ CYTK announced 66 RNAi Therapeutic 66 XOMA 3AB 66 2 inhibitor CYT# 66 Epratuzumab 66 XL# XL# XL# XL# 66 Medidur TM FA 66 Clolar ® 66 immunotherapeutic agent 66 crizotinib PF # 66 bardoxolone 66 NasdaqGM SPPI 66 CUSTOM III 66 Corlux 66 anticoagulant reversing agent 66 MCSP respectively 66 Kahalalide F 66 sorafenib Nexavar 66 Neuradiab 66 Omacetaxine 66 hyaluronidase enzyme 66 recurrent glioblastoma multiforme 66 G#DT 66 Initiates Clinical Trial 66 NEUVENGE 66 Aganocide 66 tanespimycin 66 personalized dendritic 66 dasatinib Sprycel 66 Medullary Thyroid Cancer 66 AKT inhibitor 66 product platforms AZX# 66 sunitinib Sutent 66 NEUMUNE 66 Trofex TM 66 pivotal bioequivalence 66 pemetrexed Alimta 66 Pafuramidine 66 BCR ABL inhibitor 66 palifosfamide Zymafos TM 66 tiuxetan 66 VeriStrat 66 Calcium Acetate 66 velafermin 66 ALN VSP 66 pradefovir 66 #/#/# Cytokinetics Incorporated 66 HepaGam B 66 ALN HPN 66 Protexia ® 66 hormone LHRH antagonist 66 using Crucell PER.C6 66 ATPace TM 66 Veronate R 66 Catena ® 66 hypoxia activated prodrug 66 NYSE Amex PBTH 66 CCR5 mAb 66 Zybrestat 66 sodium Injection 66 L BLP# 66 Stimuvax R 66 DCVax R 66 Enzyme Replacement Therapy 66 herpetic keratitis 66 Reports Preclinical Data 66 Pertuzumab 66 depsipeptide 66 DXL# 66 RIGScan CR 66 OMNARIS HFA 66 Hsp# Inhibitor 66 Lovaxin C 66 registrational trial 66 ImmuKnow R 66 Leukine ® 66 Canvaxin TM 66 EVIZON TM 66 phase IIb trial 66 Troxatyl 66 #I TM# 66 Nipent R 66 candidate REP# 66 ADVANCE PD 66 investigational antiplatelet agent 66 BAL# [002] 66 solithromycin 66 StemEx R 66 ORENCIA R 66 OncoGel 66 lomitapide 66 hoFH 66 LibiGel ® 66 Phase #b/#a 66 BARACLUDE R 66 trastuzumab Herceptin R 66 CHAMPION PCI 66 epothilone 66 treat refractory angina 66 ancrod 66 Randomized Double blind 66 ularitide 66 Azedra TM Onalta TM 66 cilengitide 66 delafloxacin 66 lapatinib Tykerb 66 Vicinium TM 66 recombinant biopharmaceutical 66 celgosivir 66 ANYARA 66 TRX1 66 Enzastaurin 66 Ganite ® 66 GW# [003] 66 Soliris eculizumab 66 histone deacetylase inhibitor 66 Etubics 66 MEK Inhibitor 66 IDI MRSA 66 ABL inhibitor 66 external counterpulsation systems 66 initiate Phase 1b 66 SIX RO ROG 66 advanced metastatic renal 66 nilotinib Tasigna ® 66 molecular imaging radiopharmaceuticals 66 Thiarabine 66 anti CD# antibodies 66 antisense inhibitors 66 Neulasta R 66 Phase #/#a 66 brivanib 66 Vidaza R 66 EGFr expressing metastatic colorectal 66 ongoing Phase IIIb 66 telaprevir VX 66 IV Busulfex 66 phase Ib 66 Commences Phase 66 Therapeutic Vaccine 66 ganaxolone 66 sunitinib Sutent ® 66 deforolimus 66 cutaneous T 66 Crofelemer budesonide foam 66 dextromethorphan quinidine 66 verteporfin 66 rhMBL 66 RenaZorb TM 66 CCR5 antagonist 66 zanolimumab 66 initiate multicenter 66 IMPACT DCM 66 Hematide ™ 66 TACI Ig 66 preclinical pharmacokinetic 66 sapacitabine CYC# 66 Motesanib 66 TRO# 66 GSK# [002] 66 Genasense ® 66 HDAC Inhibitor 66 Maribavir 66 Mipomersen 66 DOS# 66 Phenoptin 66 HCV SPRINT 66 indibulin 66 Diabetic Macular Edema DME 66 Phase III confirmatory 66 Hepatitis C Virus HCV 66 APEX PD 66 SNALP technology 66 Phase III ADT 66 MVA BN R 66 intravesical infusion therapy 66 ORENCIA ® 66 nalbuphine ER 66 Lauren Silvernail 66 mitogen activated ERK kinase 66 BEXXAR 66 Hyphanox 66 EP #R 66 Acute Radiation Syndrome ARS 66 metastatic colorectal 66 vaginally administered lidocaine 66 cetuximab Erbitux 66 GeneICE 66 BRAF inhibitor 66 Dasatinib 66 MYCAMINE 66 investigational protease inhibitor 66 Homspera TM 66 ponatinib 66 metastatic neuroendocrine tumors 66 IAP inhibitors 66 Pegloticase 66 EXPAREL TM 66 Successfully Completes Phase 66 squamous non 66 treatment naive genotype 66 MEK inhibitor RDEA# 66 Nasdaq IDRA today 66 BiTE antibody 66 Cervista HPV HR 66 GTC recombinant human 66 Sulonex TM 66 MYDICAR 66 human IgG1 monoclonal 66 Spiegelmer ® 66 teriflunomide 66 Shigamabs ® 66 Combidex 66 Aplidin R 66 isatoribine 66 Achieves Primary Endpoint 66 polymerase inhibitor 66 Myocet 66 Phase 2b Clinical Trial 66 Hedgehog pathway inhibitor 66 Pivotal Phase II 66 HCV antiviral 66 KRN# 66 evaluating picoplatin 66 oral salmon calcitonin 66 subcutaneous PRO 66 IgG1 monoclonal antibody 66 vismodegib 66 cellular immunotherapy 66 NovaBay Aganocide compounds 66 XmAb 66 JOULFERON 66 Vidaza ® 66 Oncaspar 66 Miraxion Amarin lead 66 alemtuzumab MS 66 ENABLE Phase 2 66 Pharmos proprietary 66 ALTROPANE 65 XmAb# 65 LentiVector technology 65 Allovectin 7 ® 65 Tezampanel 65 Entereg R 65 Cloretazine R 65 Initiated Phase 65 cMET 65 EndoTAG TM -1 65 ACTEMRA TM 65 Prednisporin 65 generation URAT1 inhibitor 65 Onalta TM 65 Neuvenge 65 ImmunoGen TAP technology 65 Novel Oral 65 alkylating agent 65 Romiplostim 65 GelSite polymer 65 Investigational Oral 65 Pazopanib 65 isoform selective 65 cleavable linker 65 metastatic castration resistant 65 Protexia R 65 imetelstat GRN#L 65 anti CD3 monoclonal 65 HCV NS5B polymerase 65 Saforis 65 standard chemotherapy regimen 65 Zorbtive TM 65 candidate XP# 65 Hepatitis C HCV 65 incyclinide 65 DUROS 65 EXPLORE Xa 65 VitiGam 65 Therapeutic Competitors companiesandmarkets.com adEgemonye 65 reslizumab 65 Pivotal Phase 65 p# biomarker 65 Onco TCS 65 AVADO 65 Eculizumab 65 selective androgen receptor modulator 65 Genz # 65 XL# XL# 65 Traficet EN 65 Aganocide R 65 Tovaxin ® 65 ZK EPO 65 evaluating Prochymal 65 PRTX 65 candidates Azedra TM 65 investigational hepatitis B 65 Daclizumab 65 trabectedin 65 NASDAQ PCYC 65 MEND CABG II 65 molecular imaging radiopharmaceutical 65 HepeX B TM 65 Severe Sepsis 65 GEM OS2 65 randomized Phase IIb 65 elacytarabine 65 terlipressin 65 DASISION 65 JAK2 Inhibitor 65 IRX 2 65 Altera Nebulizer System 65 CANCIDAS 65 BXT # 65 Sym# 65 Randomized Phase II 65 CYC# 65 Nanobody 65 PEP# [003] 65 Metastatic Melanoma 65 Bioral Amphotericin B. 65 relapsing remitting MS RRMS 65 DermaVir Patch 65 Copegus ribavirin 65 EDEMA3 65 multicenter Phase 65 HuCAL GOLD R 65 NASDAQ SNTA 65 Alinia 65 CAMPATH 65 CCR9 antagonist 65 genomic biomarker 65 Trofex ™ 65 Dual Opioid 65 IMPACT IMmunotherapy 65 PNT# 65 LibiGel ® testosterone gel 65 catheter occlusion 65 faropenem 65 dimebon latrepirdine 65 Arzerra TM 65 bosutinib 65 ZFP Therapeutics 65 LymphoStat B belimumab 65 Phase IIIb clinical 65 Removab 65 MAXY alpha 65 nucleotide analog 65 agonistic human 65 EXPAREL ™ 65 NO# [002] 65 Ophena TM 65 Urocortin 2 65 SIR Spheres 65 Chimigen TM 65 XmAb ® 65 Anavex #-# 65 Oral NKTR 65 thiazolides 65 Nasdaq PPHM 65 SNT MC# 65 opioid induced bowel dysfunction 65 UVIDEM 65 immatics 65 OTCBB PYTO 65 Bioral ® 65 Junovan TM 65 Prosaptide 65 Phase 1b trial 65 Generx TM 65 YONDELIS R 65 ALN HTT 65 octreotide acetate 65 esophageal candidiasis 65 Randomized Phase 65 bevacizumab Avastin 65 CIP TRAMADOL ER 65 drug ISA# 65 Targretin 65 therapeutic monoclonal antibodies 65 Neo Kidney Augment 65 ® decitabine 65 inhaled AAT 65 immunotherapeutic vaccine 65 oral talactoferrin 65 sNDA submission 65 HuCNS SC ® 65 diarrhea predominant irritable 65 Valortim R 65 PEGylated interferon 65 mapatumumab 65 HEPLISAV TM 65 Genasense oblimersen sodium Injection 65 LEVADEX ™ 65 synthetic retinoid 65 BHT DNA 65 PROGENSA R 65 Thalomid ® 65 Phase IIa trials 65 Orathecin 65 Angiocept 65 TKM ApoB 65 Uvidem 65 ™ pralatrexate injection 65 Alfacell proprietary ribonuclease 65 Kamada AAT 65 HCV polymerase 65 investigational monoclonal antibody 65 prostone 65 rALLy trial 65 STRIDE PD 65 Phase 1b clinical 65 Inotek Pharmaceuticals Corporation 65 Solazed 65 HTS assay 65 TKB# 65 Phase IIIb study 65 apoptosis inducer 65 Pemetrexed 65 trastuzumab Herceptin ® 65 initiated Phase 1b 65 NP2 65 subcutaneous formulation 65 preclinical toxicology 65 ESBA# 65 PKC# 65 Urocidin TM 65 randomized controlled multicenter 65 PEG INTRON R 65 2 methoxyestradiol 65 LAF# 65 Tovaxin TM 65 Degarelix 65 nasal decolonization 65 rNAPc2 65 darinaparsin ZIO 65 pain palliation 65 TPI ASM8 65 INSPIRE Trial Phase III 65 IMPDH inhibitor 65 humanised antibody 65 PGL# 65 Phase IIIb 65 unique alkylating agent 65 Meets Primary Endpoint 65 virus HCV infection 65 introduced NEUGENE 65 Allovectin 7 R 65 Transdrug ® nanoparticle 65 aflibercept 65 LUNESTA TM 65 CD# antibody [001] 65 topoisomerase II inhibitor 65 Fx #A 65 SYCREST 65 entinostat 65 HER2 antibody 65 novel peptide 65 CLORETAZINE TM VNP#M 65 histone deacetylase HDAC 65 GRN# 65 sarcoma melanoma 65 Nexavar sorafenib tablets 65 evaluating Actimmune 65 bortezomib Velcade R 65 drug pipeline TAFA# 65 molecular chaperone regulation 65 selective immunoproteasome inhibitor 65 REG1 Anticoagulation System 65 recurrent NSCLC 65 hematological cancers 65 pharmacogenomic translational research 65 glufosfamide 65 custirsen 65 Phase III Clinical Trial 65 targeting CD# 65 INTEGRILIN R eptifibatide Injection 65 polymerase inhibitors 65 SinuNase 65 relapsed leukemia 65 miRview meso 65 Sudhir Agrawal D.Phil 65 Phase IIb Trial 65 inhibitor RG# 65 JAK2 inhibitor 65 LBH# 65 sargramostim 65 novel oral anticoagulant 65 Fabry Disease 65 gastrointestinal stromal tumors GIST 65 humanized anti 65 Phase IIb trials 65 Tarvacin TM 65 Intravenous Human 65 microtubule inhibitor 65 motexafin gadolinium Injection 65 ELND-#/AZD-# 65 small molecule tyrosine 65 Nasdaq DVAX 65 forodesine hydrochloride 65 antibiotic candidate Ramoplanin 65 Celgosivir 65 Presents Preclinical Data 65 Zolinza 65 omega interferon 65 metastatic castrate resistant 65 vapreotide acetate 65 Diabetic Macular Edema 65 cisplatin gemcitabine 65 investigational hepatitis C 65 Darinaparsin 65 IMPACT DCM clinical 65 anti CD3 antibody 65 OvaRex 65 confirmatory clinical 65 sipuleucel T 65 Phase 2a clinical 65 Biologic License Application BLA 65 randomized controlled Phase 65 RELOVAIR ™ 65 Phase lll 65 Bellicum Pharmaceuticals Inc. 65 Campath alemtuzumab 65 INxin TM 65 Vion Pharmaceuticals 65 GSK '# 65 Aclidinium 65 lesinurad 65 PFO migraine 65 epothilones 65 rituximab Rituxan 65 aleglitazar 65 Ixempra 65 Rhucin ® recombinant 65 budesonide MMX Phase III 65 intranasal formulation 65 riociguat 65 candidate deforolimus 65 cetuximab Erbitux ® 65 Duromist ™ 64 Omnitarg 64 budesonide foam 64 Telavancin 64 epigenetic therapies 64 Novolimus 64 multicenter Phase III 64 NVA#